FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ferriprox (deferiprone) from Chiesi USA, Inc., signaling an approved modification to its existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload

Drugs mentioned

• FERRIPROX (deferiprone)

Snippet

SUPPL AP for FERRIPROX (DEFERIPRONE)